Brief: Variant Pharmaceuticals Secures $10 Million In Financing

Incon

03/12/2018 12:15

Dec 3 (Reuters) - Variant Pharmaceuticals: 
    * VARIANT PHARMACEUTICALS SECURES $10 MILLION IN FINANCING
FROM
KOREAN COMPANY, INCON CO., LTD.
    * VARIANT PHARMACEUTICALS-INCON GRANTED EXCLUSIVITY PERIOD
TO
NEGOTIATE RIGHTS TO SELL, DISTRIBUTE CO'S RENAL PIPELINE
COMPOUNDS IN SOME ASIAN COUNTRIES

Source text for Eikon:  ID:nPn7Ckw5fa 
Further company coverage:  083640.KQ 

 ((Reuters.Briefs@thomsonreuters.com;))